Kain Capital LLC
Kain Capital LLC is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Kain Capital LLC.
Kain Capital LLC is a company.
Key people at Kain Capital LLC.
Key people at Kain Capital LLC.
Kain Capital LLC is a New York-based, healthcare-focused private equity firm founded in 2014 that partners with motivated entrepreneurs leading mid-sized, founder-led companies to drive transformational change through technology enablement and operational growth.[2][3][4] Its mission centers on fostering impact-driven investments in stable healthcare businesses, emphasizing deep collaboration to harness scale via information technology while improving patient access, care quality, and financial accountability.[1][2] The firm targets key sectors like primary care, hospice and palliative care, workers' compensation clinics, autism therapy (ABA centers), and specialty care, significantly impacting the startup and mid-market ecosystem by funding expansions, mergers, and de novo builds—such as growing providers by 75%, converting patients to risk-based models, and launching platforms for underserved populations.[1][3]
Kain Capital was established in 2014 in New York City as a growth-focused private equity fund, evolving from a strategy of deep, collaborative involvement with business partners to create long-term value in healthcare services.[3][4] Key figures include Bret Cummings (Chief Financial Officer and Chief Compliance Officer), Harry Zirinsky (Head of Business Development and Strategy), Idan Eidlman (Vice President), and Jake Landau (Senior Associate), reflecting a compact team (<25 employees) headquartered at 360 Madison Ave Fl 20.[3][4] The firm's focus has sharpened on technology-enabled healthcare, launching initiatives like PERA LLC for hospice acquisitions with veteran executives and investments in platforms like Excelsior (merged with Rendr Care in 2022) and an autism therapy build-out starting in 2021, adapting to market shifts such as workers' comp clinic deterioration.[1][4]
Kain Capital rides the wave of healthcare's rapid digitization, where information technology enables scale in fragmented sectors like primary care, behavioral health, and workers' comp, amid trends toward value-based care and capitated contracts.[1][2] Timing aligns with post-2022 consolidations (e.g., Excelsior-Rendr merger) and demand for alternatives to declining incumbents, fueled by employer needs for cost-effective care and family access to therapies for conditions like autism.[1] Market forces favoring Kain include aging populations boosting hospice/palliative demand, underserved niches (e.g., Asian-focused care, ABA centers), and tech's role in risk-sharing models; the firm influences the ecosystem by pioneering platforms like Akeso's tech for clinics and PERA's best practices, bridging independent providers with scalable operations.[1][3]
Kain Capital is poised for continued expansion in tech-enabled healthcare, with funds open as recently as May 2025 signaling fresh capital deployment into consolidations and de novos amid rising demand for accessible, accountable care.[1][4] Trends like AI-driven therapies, full-risk adoption, and regional operator roll-ups will shape its path, potentially amplifying influence through broader tech offerings from portfolio innovations (e.g., Akeso's tools).[1] As mid-market fragmentation persists, Kain's founder-centric model positions it to evolve as a key enabler of efficient, impact-focused healthcare transformation, building on its track record of patient growth and market voids filled.[2][3]
